Clinical and electrophysiological effects of apomorphine in Parkinson's disease patients are not paralleled by amino acid release changes: A microdialysis study

Functional Neurology

Volumn 16, Issue 1, 2001, Pages 57-66

  Fedele, Ernesto ^e   Stefani, Alessandro ^a,b   Bassi, Andrea ^b   Pepicelli, Olimpia ^e   Altibrandi, Maria Grazia ^c   Frasca, Stefania ^a   Giacomini, Patrizia ^d   Stanzione, Paolo ^a   Mazzone, Paolo ^c  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c CTO Hospital ASL Roma C   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; AMINO ACID; APOMORPHINE; BIOCHEMICAL MARKER; DOPAMINE RECEPTOR; GLUTAMIC ACID;

ADULT; AGED; AMINO ACID BRAIN LEVEL; AMINO ACID SYNTHESIS; BRAIN DEPTH STIMULATION; BRAIN ELECTROPHYSIOLOGY; CELL LEVEL; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; ELECTRODE; FEMALE; GLOBUS PALLIDUS; HUMAN; MALE; MICRODIALYSIS; PARKINSON DISEASE; PERIOPERATIVE PERIOD; RELIABILITY; STEREOTAXIC SURGERY; SUBTHALAMIC NUCLEUS;

AGED; AMINO ACIDS; APOMORPHINE; BRAIN; BRAIN MAPPING; ELECTRODES, IMPLANTED; ELECTROENCEPHALOGRAPHY; FEMALE; GAMMA-AMINOBUTYRIC ACID; GLOBUS PALLIDUS; GLUTAMIC ACID; HUMANS; MALE; MICRODIALYSIS; MIDDLE AGED; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; SUBTHALAMIC NUCLEUS;

EID: 0035020496     PISSN: 03935264     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (33)

1. Albin RL, Young AB, Penny JB. The functional anatomy of the basal ganglia. Trends Neurosci 1989;12:366-375
2. DeLong MR. Primate models of movement disorders of basal ganglia origin. TINS 1990;13:281-285
3. Lang A, Lozano AM. Parkinson's disease. Second of two parts. N Engl J Med 1998; 339:1130-1143
4. Hutchison WD, Levy R, Dostrovsky JO, Lozano AM, Lang AE. Effects of apomorphine on globus pallidus neurons in parkinsonian patients. Ann Neurol 1997;42:767-775
5. Stefani A, Stanzione P, Bassi A, Mazzone P, Vangelista T, Bernardi G. Effects of increasing doses of apomorphine during stereotaxic neurosurgery in Parkinson's disease: clinical score and globus pallidus activity. J Neurol Transm 1997; 104:895-904
6. Stefani A, Mazzone P, Bassi A et al. Electrophysiological and clinical desensitization to apomorphine administration in parkinsonian patients undergoing stereotaxic neurosurgery. Exp Neurol 1999;156: 209-213
7. Fahn S, Elton RL and members of the UPDRS Development Committee. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB eds Recent Developments in Parkinson's Disease, Vol. 2. Florham Park NJ; Macmillan 1987:153-163,293-304
8. Hutchison WD, Allan RJ, Opitz H et al. Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson's disease. Ann Neurol 1998;44:622-628
9. Meyerson BA, Linderoth B, Karlsson H, Ungersted U. Microdialysis in the human brain: extracellular measurements in the thalamus of parkinsonian patients. Life Sci 1989;46:301-308
10. Marsden CD. On-offphenomena in Parkinson's disease. In: Rinne UK, Klinger M, Stamm G eds Parkinson's Disease: Current Progress, Problems and Management. Amsterdam; Elsevier/North Holland-Biochemical Press 1980:241-254
11. Marsden CD, Parkers JD, Quinn N. Fluctuations in disability in Parkinson's disease: clinical aspects. In: Marsden CD, Fahn S eds Movement Disorders. New York; Butterworth Scientific 1982:96-122
12. Caltagirone C, Gainotti C, Masullo C, Miceli G. Validity of some neuropsychological tests in the assessment of mental deterioration. Acta Psychiatr Scand 1979;60:50-56
13. Limousin P, Pollak P, Benazzouz A et al. Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 1995;345:91-95
14. Talairach J, David M, Tournoux P, Corredor H, Kvasina T. Atlas d'Anatomie Stereotaxique. Paris; Masson 1957
15. Shaltenbrand G, Wahren W. Atlas for Stereotaxy of the Human Brain. Stuttgart; Georg Thieme 1977
16. Fedele E, Varnier G, Ansaldo MA, Raiteri M. Nicotine administration stimulates the in vivo N-methyl-D-aspartate receptor/nitric oxide/cyclic GMP pathway in rat hippocampus through glutamate release. Br J Pharmacol 1998;125:1042-1048
17. Kanthan R, Shuaib A, Griebel R, el Azzouni H, Miyashita H, Karla J. Evaluation of monoaminergic neurotransmitters in the acute focal ischemic human brain model by intracerebral in vivo microdialysis. Neurochem Res 1996a;21:563-566
18. Kanthan R, Shuaib A, Griebel R, Miyashita H, Karla J. Glucose-induced decrease in glutamate levels in ischemic human brain by in vivo microdialysis. Neurosci Lett 1996b;209:207-209
19. Zauner A, Bullock R, Kuta AJ, Woodward J, Young HF. Glutamate release and cerebral blood flow after severe human head injury. Acta Neurochir Suppl 1996;67:40-44
20. Vespa P, Prins M, Ronne-Engstrom E et al. Increase in extracellular glutamate caused by reduced cerebral perfusion-pressure and seizures after human traumatic brain injury: a microdialysis study. J Neurosurg 1998;89:971-982
21. Koura SS, Doppenberg EM, Marmarou A, Choi S, Young HF, Bullock R. Relationship between excitatory amino acid release and outcome after severe human head injury. Acta Neurochir Suppl 1998;71:244-246
22. Valadka AB, Goodman JC, Gopinath SP, Uzura M, Robertson CS. Comparison of brain tissue oxygen tension to microdialysis-based measures of cerebral ischemia in fatally head-injured humans. J Neurotrauma 1998;15:509-519
23. Persson L, Valtysson J, Enblad P et al. Neurochemical monitoring using intracerebral microdialysis in patients with subarachnoid hemorrhage. J Neurosurg 1996:84:606-616
24. Shuaib A, Kanthan R, Goplen G et al. Invivo microdialysis study of extracellular glutamate response to temperature variance in subarachnoid haemorrhage. Acta Neurochir Suppl 1996;67:53-58
25. Wilson CE, Maidment NT, Shomer MH et al. Comparison of seizure related amino acid release in human epileptic hippocampus versus a chronic kainate rat model of hippocampal epilepsy. Epilepsy Res 1996;26:245-254
26. Bolam JP, Smith Y. The striatum and the globus pallidus send convergent synaptic inputs onto single cells in the entopeduncular nucleus of the rat: a double anterograde labelling study combined with postembedding immunocytochemistry for GABA. J Comp Neurol 1992;321:456-476
27. Smith Y, Witchmann T, DeLong MR. Synaptic innervation of neurones in the internal pallidal segment by the subthalamic nucleus and the external pallidum in monkeys. J Comp Neurol 1994;343:297-318
28. Shink E, Smith Y. Differential synaptic innervation of neurones in the internal and external segments of the globus pallidus by the GABA-and glutamate-containing terminals in the squirrel monkey. J Comp Neurol 1995;358:119-141
29. Shink E, Bevan MD, Bolam JP, Smith Y. The subthalamic nucleus and the external pallidum: two tightly interconnected structures that control the output of the basal ganglia. Neuroscience 1996;73:335-357
30. Pasik P, Pasik T, Holstein GR, Hamori J. GABAergic elements in the neuronal circuits of the monkey neostriatum: a light and electron microscopic immunocytochemical study. J Comp Neurol 1988;270:157-170
31. Timmerman W, Westerink BH. Brain microdialysis of GABA and glutamate: what does it signify? Synapse 1997;27:242-261
32. Nutt JG, Woodward WR. Long-duration response to levodopa. Neurology 1995;45: 1613-1616
33. Zappia M, Colao R, Montesani R et al. Long-duration response to levodopa influences the pharmacodynamics of short response in Parkinson's disease. Ann Neurol 1997;42:245-248